Mobvoi Inc (Ticker: 2438 HK) is an artificial intelligence company headquartered in Beijing, China. Founded on October 1, 2012, by Zhifei Li and Yuanyuan Li, Mobvoi specializes in consumer electronics and develops Chinese voice recognition, natural language processing, and vertical search technology. Their core team consists of former Google employees and experts from leading universities and tech companies. The company offers products such as Chumenwenwen Mobile Voice Search, TicAuto (in-vehicle speech recognition), TicMirror (smart rear-view mirror), TicEye (driver assistance system), and a series of smartwatches under the TicWatch brand.
Mobvoi Inc will list on April 24, 2024, on the Hong Kong Stock Exchange. The company plans to offer 84.57 million shares, with an expected price range of HKD 3.70 to 4.10. The offering includes a 15% greenshoe option, potentially increasing the total shares to 97.26 million if exercised. The IPO is managed by CMB International Capital Corp Ltd, China International Capital Corp HK Securities, and Shenwan Hongyuan Securities HK Ltd. The total offer size is projected to be HKD 346.73 million (USD 44.27 million).

Sichuan Baicha Baidao Industrial Co Ltd (Ticker: 2555 HK) is a China-based company operating in the beverages industry, specifically focusing on the production and sale of bubble tea. The company is set to list on the Hong Kong Exchange on April 23, 2024. Sichuan Baicha Baidao is offering 147.76 million shares at a price of HKD 17.50 each. The expected market capitalization at the offer is HKD 25.86 billion (approximately USD 3.30 billion). The total offer size is HKD 2.59 billion (USD 330.32 million).
The IPO is managed by CCB International Capital Ltd, CMB International Capital Corp Ltd, China International Capital Corp HK Securities, and China Merchants Securities (HK) Co Ltd.

Lianlian DigiTech Co Ltd (Ticker: 2598 HK) is a Chinese fintech primarily engaged in providing digital payment solutions. It operates globally, with a significant presence in more than 100 countries and supports over 130 currencies. Lianlian DigiTech is known for its extensive partnership network with e-commerce platforms such as Amazon, Shopee, and Shopify. Additionally, the company collaborates with American Express affiliates in China through a venture named LianTong, offering payment intermediation services.

Lianlian DigiTech will list on March 28 in Hong Kong. The firm plans to sell 55.92 million shares at an expected price range of HKD 10.21 to HKD 10.95 (USD 1.30 to USD 1.40), aiming to raise up to HKD 612 million (USD 78.26 million). The offering is managed by ABCI Capital Ltd, BNP Paribas Securities Asia Ltd, Caitong International Securities Co Ltd, China Galaxy International Securities Hong Kong, among others. Proceeds from the IPO are intended for technological advancements and global business expansion, with a focus on building an advanced, modular distributed-payment platform, enhancing risk management through generative AI, and developing a scalable cloud-based data center.

Palasino Holdings Ltd (Ticker: 2536 HK) is an entertainment company based in Hong Kong, operating within the gambling and hospitality industry. The company has a diverse portfolio that includes one integrated land-based casino and resort, two full-service land-based casinos in the Czech Republic, and four hotels in Germany and Austria offering accommodation, catering, conference, and leisure services. Palasino Holdings Ltd will list on the Hong Kong Stock Exchange on March 26, 2024. The firm plans to raise HKD 371.43 million (USD 47.50 million) by offering 142.86 million shares. The expected price range for the shares is HKD 2.60 (USD 0.33) each. The IPO is managed by CCB International Capital Ltd, CMB International Capital Corp Ltd, Guosen Securities HK Capital Co Ltd, Guotai Junan Securities (Hong Kong) Ltd, Livermore Holdings Ltd, and others.

The company's operations have expanded since being acquired by the FEC Group in 2018, including the addition of new slot machines, the launch of poker games, and rebranding their casinos to "Palasino." The IPO marks a spin-off from the FEC Group. Palasino Holdings has a long operating history in central Europe, with its first establishment dating back to 1995. Despite challenges posed by COVID-19, leading to temporary closures, the company has shown significant growth, with revenue increasing notably over the past years.

Migao Group Holdings Ltd (Ticker: 9879 HK) is a chemicals company based in China, specializing in the specialty chemicals sector with a focus on potash fertilizer production. The company is set to list on the Hong Kong Stock Exchange on March 21, 2024, aiming to raise HKD 967.50 million (approximately USD 123.68 million) by offering 225.00 million shares at a price of HKD 4.30 (USD 0.55) per share. The offering also includes a greenshoe option of 15%, amounting to 33.75 million additional shares. The IPO is managed by a consortium of underwriters including ABCI Capital Ltd, CMB International Capital Corp Ltd, China Everbright Securities (HK), China Merchants Securities (HK) Co Ltd, and Essence International Securities Hong Kong.

Migao Group Holdings positions itself as one of the largest potash fertilizer companies in China in terms of sales volume. The company focuses on various potash fertilizer products, including potassium chloride (KCL), potassium sulfate (SOP), potassium nitrate (NOP), and compound fertilizers Migao Group Holdings has been recognized for to be among the "Top Ten Potash Fertilizers of China" and the "Top 100 Chemical Fertilizer Enterprises of China" since 2016.

Qyuns Therapeutics Co. Ltd (Ticker: 2509 HK) is a pharmaceuticals company based in China, specializing in the development of clinical-stage biologic antibody drugs for autoimmune and allergic diseases. The company plans to list its shares on the Hong Kong Stock Exchange on March 20, 2024. Qyuns Therapeutics aims to raise HKD 243.33 million (approximately USD 31.10 million) by offering 12.05 million shares. The expected price range for the IPO is HKD 20.20 per share. The offering is managed by a consortium including China Industrial Securities International, China International Capital Corp HK Securities, Essence International Securities Hong Kong, and Guotai Junan Securities (Hong Kong).
The company utilizes a rabbit-based discovery platform for its pipeline of nine candidates, aiming to offer more affordable solutions with better affinity and greater diversity than traditional mouse-based technologies. The IPO proceeds are intended to fund the development of Qyuns Therapeutics' portfolio, including their anticipated first approved drug, QX001S, a ustekinumab biosimilar aimed at treating psoriasis.

Changjiu Holdings Ltd (Ticker: 6959 HK) is a Technology company, specifically in the Software & Tech Services industry, providing vehicle monitoring services and automobile dealership operation management services. The company mainly serves financial institutions, automobile dealerships, and automobile finance companies in China. Changjiu Holdings Ltd will list on January 9, 2024, in Hong Kong. The firm is selling 50.54 million shares at an expected price range of HKD 5.95 - 7.90. The total offer size is HKD 399.27 million (USD 51.12 million). The offering details, including underwriters and offer managers, are currently unspecified.

Concord Healthcare Group Co., Ltd (Ticker: 2453 HK) is a Hong Kong-based company operating in the Medical Labs & Testing Services industry. Affiliated with Concord Holdings listed on the New York Stock Exchange, the company specializes in cancer prevention, diagnosis, and treatment, and also offers financial leasing and investment in healthcare-related enterprises. With a presence Chinese cities like Beijing, Shanghai, and Guangzhou, Concord Healthcare Group Co., Ltd provides both offline and online medical services, including precision radiotherapy and Internet medical services.

The company is scheduled to list on the Hong Kong Stock Exchange on January 9, 2024. It plans to offer 39.42 million shares, with an expected price range of HKD 14.10 to HKD 16.40 per share, aiming to raise HKD 646.4913 million (USD 82.77 million). The IPO is managed by a consortium of underwriters including ABCI Capital Ltd, CCB International Capital Ltd, CLSA Ltd, CMB International Capital Corp Ltd, China Everbright Securities (HK), and Fosun.

Shenzhen Robosense Technology Co Ltd (Ticker: 2498 HK) is a global provider in the LiDAR and perception solutions market, particularly in the self driving car industry. Founded in 2014 and headquartered in Shenzhen, China, RoboSense specializes in advanced LiDAR sensor technologies, system on a chip, and cutting-edge perception software.

The company is set for an IPO on the Hong Kong Stock Exchange, aiming to raise HKD 985.12 million (USD 126.13 million). The expected Market Capitalization at offer is HKD 19.32 billion (USD 2.47 billion), with an offering of 22.91 million primary shares and a greenshoe option of 15%, adding approximately 3.44 million shares. The expected price is HKD 43.00 (USD 5.51) per share, with a listing anticipated on January 5, 2024. The offering is managed by ABC International Holding, CMB International Securities Ltd, and JP Morgan Securities PLC.

UBTech Robotics Corp Ltd (Ticker: 9880 HK) is a company specializing in industrial automation and robotics, based in China. The company operates in the field of intelligent service robots, offering products and solutions across various industries including AI education, smart logistics, healthcare, and consumer hardware. UBTech Robotics highlights its full-stack humanoid robotic technologies, which encompass a range of capabilities from robotic motion planning and control technology to AI technologies like computer vision and voice interaction. The company has a significant patent portfolio, with more than 1,600 robotic and AI-related patents.

UBTech Robotics announced its IPO on December 19, 2023, with plans to list on the Hong Kong Stock Exchange. The company aims to raise HKD 1.31 billion (approximately USD 167.80 million). The expected price range for the offering is HKD 86.00 to HKD 116.00 per share (USD 11.03 to USD 14.87). The offering includes 11.28 million primary shares with an additional greenshoe option of 15%, amounting to 1.69 million shares. The expected pricing date for the IPO is December 27, 2023, with an anticipated listing date of December 29, 2023. The offering is being managed by several institutions including ABCI Capital Ltd, BNP Paribas Securities Asia Ltd, BOCI Asia Ltd, and others.

BaTeLab Co. (Ticker: 2149 HK) is a manufacturer of integrated circuit wafers, specializing in analog integrated circuit research and development. Based in Suzhou, China, the company operates primarily in the high-tech sector. BaTeLab will list on the Hong Kong Stock Exchange on December 28. The firm is selling 15 million shares at a price range of HK$27.47 to HK$38.45 each. The expected offer size is HKD 577 million (USD 73.9 million). The offering is managed by CICC as the sole sponsor.

Persistence Resources Group Ltd (Ticker: 2489 HK) is a gold mining and processing company based in Yantai City, Shandong Province, China. The company, established in 2005, owns two gold mines in the region and operates additional mining infrastructure including mineral processing plants and a tailings dam. It specializes in gold exploration, mining, processing, and selling gold bullion made from in-house processed gold concentrates. Persistence Resources Group Ltd is listed as the third largest gold miner in Shandong Province as of 2022, with a market share of 2.6% according to a Frost & Sullivan report.

The company will list on the Hong Kong Stock Exchange on December 22, 2023. It plans to offer 500,000,000 shares, with an indicative offer price range of HKD 0.55 to HKD 0.75 per share. The total offer size is HKD 375.00 million (USD 48.02 million). The offering is managed by a consortium of underwriters including ABCI Capital Ltd, BOCOM International Securities Ltd, CCB International Capital Ltd, CMBC Securities Co Ltd, Citrus Securities Ltd, First Shanghai Securities Ltd, Innovax Capital Ltd, Quam Securities Co Ltd, SPDB International Capital Ltd, Valuable Capital Ltd, and others.

The proceeds from the IPO are earmarked for various purposes including selective acquisition of gold mining assets, further construction of mining infrastructure, repayment of existing bank loans, working capital, and additional exploration activities to upgrade gold reserves.

Pu'er Lancang Ancient Tea Co Ltd (Ticker: 6911 HK) is a beverage company specializing in the tea industry, specifically in the production and distribution of Pu'er tea. Based in China, the company has a history dating back to 1966.

Pu'er Lancang Ancient Tea Co Ltd announced its IPO on December 14, 2023, with the aim of raising HKD 297.36 million (USD 38.08 million). The listing is set to take place on the Hong Kong Stock Exchange, with the expected listing date being December 22, 2023. The company plans to offer 21.00 million shares, with an expected price range of HKD 10.40 to 14.16 (USD 1.33 to 1.81) per share. The offering includes a greenshoe option of 15%, amounting to an additional 3.15 million shares. The underwriters managing the offering include ABCI Capital Ltd, CMB International Capital Corp Ltd, China Merchants Securities (HK) Co Ltd, China Securities International Corporate Finance, Eddid Securities & Futures Ltd, Futu Securities International Hong Kong Ltd, Haitong International Securities Co Ltd, and ICBC.

HighTide Therapeutics Hong Kong Ltd (Ticker: 2511 HK) is a Hong Kong-based biopharmaceutical company with a focus on metabolic and digestive diseases. The company pipeline includes treatments for conditions such as nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2DM), severe hypertriglyceridemia (SHTG), primary sclerosing cholangitis (PSC), and primary biliary cholangitis (PBC). Their lead drug candidate, HTD1801, has received Fast Track designation from the U.S. FDA in 2018 for both NASH and PSC, as well as Orphan Drug designation for PSC.

HighTide Therapeutics is planning to list on the Hong Kong Stock Exchange on December 22, 2023. The company is offering 24.19 million shares at an offer price of HKD 11.50 per share, aiming to raise HKD 278.23 million (USD 35.63 million). The expected market capitalization at offer is HKD 5.92 billion (USD 758.10 million). The offering is managed by a consortium of underwriters including BOCOM International Securities Ltd, CCB International Capital Ltd, and others.

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. (Ticker: 2502 HK) is a chemicals company based in China, specializing in the production and processing of hydrogenated chemicals. Their product portfolio includes benzene, toluene, xylene, and energy products such as liquefied natural gas. Established on November 23, 2012, and later becoming a subsidiary of Henan Jinma Energy Co., Ltd., the company is situated in the high-tech Industrial Development Zone of Jiyuan City, Henan Province, with a registered capital of 717 million yuan and employing 394 people.

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. will list on December 20, 2023, in Hong Kong. The firm plans to offer 238.91 million shares, with an expected price range of HKD 1.10 to 1.50 (USD 0.14 to 0.19), aiming to raise approximately HKD 358.37 million (USD 45.89 million). The offering is managed by a consortium including ABCI Capital Ltd, ABCI Securities Co Ltd, CCB International Capital Ltd, CMB International Capital Corp Ltd, Central China International Securities Co Lt, China Everbright Securities (HK), and China Galaxy International Securities.

iMotion Automotive Technology Suzhou Co., Ltd. (Ticker: 1274 HK) is an electronics company based in China, specializing in autonomous driving solutions. The company, founded in December 2016, provides a wide range of autonomous driving solutions and products, and has formed collaborations with several top-tier OEMs in the automotive industry.

iMotion Automotive Technology Suzhou Co., Ltd. is set to launch its Initial Public Offering on December 20, 2023, in Hong Kong. The company aims to raise HKD 655.74 million (USD 83.97 million) with an offering of 22.12 million shares at a fixed price range of HKD 29.65 (USD 3.80). The offering is managed by a syndicate including CMB International Capital Corp Ltd, Citigroup Global Markets Ltd, DBS Asia Capital, Goldlink Securities Ltd, Livermore Holdings Ltd, Mouette Securities Co Ltd, and SOOCHOW SECURITIES INT.

Rept Battero Energy Co., Ltd. (Ticker: 0666 HK) is a Chinese company specializing in battery and energy storage solutions, is set to go public on December 18, 2023, on the Hong Kong Stock Exchange. The company is offering 116,070,200 H Shares, divided into 11,607,200 H Shares for the Hong Kong Public Offering and 104,463,000 H Shares for the International Offering, subject to reallocation. The shares are priced between HK$18.2 and HK$20.6 each. Through this IPO, Rept Battero Energy aims to raise up to HK$2.39 billion (approximately USD $306 million) before the exercise of any over-allotment option. Morgan Stanley and Citic Securities are serving as joint sponsors for the offering. Each H Share has a nominal value of RMB1.00.

Xiamen Yan Palace Birds Nest Industry Co Ltd (Ticker: 1497 HK) is a Pharmaceuticals company based in China, specializing in the production and distribution of food supplements including freshly stewed bird's nest and dry bird's nest. The company operates more than 700 physical stores in over 200 cities across China and maintains a presence on major e-commerce and social media platforms. Xiamen Yan Palace Birds Nest Industry Co Ltd will list on December 12, 2023, in Hong Kong. The firm is selling 32.00 million shares at an expected price range of HKD 11.00 to HKD 11.00 per share, which translates to a total offer size of HKD 352.00 million (USD 45.07 million). The offering includes a greenshoe facility of 4.80 million shares. The offering is managed by China International Capital Corp HK Securities, Citigroup Global Markets Asia Ltd, GF Securities Hong Kong Brokerage Ltd, and Valuable Capital Ltd.

Dekon Food and Agriculture Group (Ticker: 2419 HK) is an agriculture company based in China, specializing in pig and yellow-feathered broiler breeding. The company has announced its Initial Public Offering (IPO) on the Hong Kong Exchange. Dekon Food and Agriculture Group is known for its vertically integrated business model that spans the entire industrial chain, from feed production to breeding, rearing, and the sale of live pigs and broiler chickens. The company plans to expand into slaughtering, processing, and the sale of meat products. In 2022, the company reported a revenue increase of 52% year-over-year to RMB 15 billion, turning a profit of RMB 992 million, in contrast to a loss in the previous year.

The company is set to list on December 6, 2023 and plans to offer 26.91 million shares, with an expected price range of HKD 30.35 to 36.95 (USD 3.90 to 4.74). The total offer size is HKD 994.40 million (USD 127.66 million). The offering is managed by a consortium of underwriters including ABCI Capital Ltd, BOCI Asia Ltd, CMB International Capital Corp Ltd, and several others.

K Cash Corp Ltd (Ticker: 2483 HK) is a Hong Kong-based company operating in the Finance industry. The company specializes in providing consumer loan services, including personal and property loans, through both physical branches and an online platform. They offer a variety of loan options with features like rapid approval, 24-hour cash lending, and AI-driven financial services. K Cash Corp Ltd is scheduled to list on the Hong Kong Stock Exchange on December 5, 2023. The company plans to offer 125.00 million shares at an expected price range of HKD 1.64 - 1.96. The total offer size is HKD 245.00 million (USD 31.45 M). The IPO is managed by CCB International Capital Ltd, DBS Asia Capital, Elstone Securities Ltd, Ping An of China Securities Hong Kong Co Ltd, and Valuable Capital Ltd.

Sino-Synergy Hydrogen Energy Technology Jiaxing Co Ltd (Ticker: 9663 HK), a company in the Automotive/Truck Parts & Equipment industry, specializing in hydrogen fuel cell manufacturing. Founded in June 2015, Sino-Synergy aims to become a leading player in China's commercial vehicle hydrogen fuel cell market. The company operates hydrogen fuel cell stack production facilities, certified under ISO9001:2015 and IATF16949:2016. Their focus is on delivering high-quality hydrogen fuel cell products and solutions, contributing to solving energy and environmental issues.

Sino-Synergy is slated to launch its IPO on the Hong Kong Stock Exchange on December 5, 2023. The company aims to raise HKD 1.70 billion (USD 217.94 million). The expected price range for the IPO is HKD 19.35 to HKD 21.35 per share, with 79.52 million shares being offered. The IPO is being managed by a consortium of underwriters including CMB International Capital Corp Ltd, GF Securities Hong Kong Brokerage Ltd, Haitong International Securities Co Ltd, Huatai Financial Holdings Hong Kong Ltd, and Livermore Holdings Ltd.

Shanxi Installation Group Co Ltd (Ticker: 2520 HK) is an Engineering and Services company based in China. The company, which began as Shanxi Equipment Installation and Engineering Company in 1955, has transformed into a large state-owned general contracting enterprise. It is the largest installation and construction enterprise in Northwest China and participates in various sectors including engineering design, construction, international labor export, equipment manufacturing, real estate development, and industrial investment. Shanxi Installation Group Co Ltd will list on November 22, 2023, in Hong Kong.

The firm is offering 333.33 million shares at an offer price of HKD 2.18 (USD 0.2791). This values the company at a market capitalization of HKD 2.91 billion (USD 372.14 million) at offer. The total offer size is HKD 726.67 million (USD 93.04 million). The offering is managed by BOCOM International Securities Ltd, CMB International Capital Corp Ltd, China Everbright Securities (HK), Futu Securities International Hong Kong Ltd, Huatai Financial Holdings Hong Kong Ltd, ICBC International Capital Ltd, Shanxi Securities, and Zhongtai International Securities Ltd.

WuXi XDC Cayman Inc (Ticker: 2268 HK), a company in the Medical - Biomedical/Gene industry, announced an Initial Public Offering on November 7, 2023. The firm, a Wuxi Biologics subsidiary specializing in contract research and manufacturing services in the pharmaceutical and biotechnology sectors, is based in China and will list on the Hong Kong Stock Exchange. WuXi XDC Cayman Inc plans to raise HKD 3.68 billion (USD 470.09 million) through the offering. The expected price range for the shares is HKD 19.90 to 20.60. A total of 178.45 million shares will be offered. The listing is tentatively scheduled for November 17, 2023. The offering is managed by China International Capital Corp HK Securities, Citigroup Global Markets Asia Ltd, Goldman Sachs (Asia), Huatai Financial Holdings Hong Kong Ltd, and Morgan Stanley Asia Ltd. The IPO is part of a strategic move to expand WuXi XDC's contract services in a growing market, with parent WuXi Biologics set to reduce its stake to 50.9% post-listing.

Folangsi Co Ltd (Ticker: 2499 HK) is a company in the forklift service industry. The company offers forklift sales, rental, and service and has introduced a platform-based chain business model in China's forklift sector. Founded in 2007 with its headquarters in Guangzhou, Folangsi operates and oversees over 27,000 on-site logistics equipment units throughout China. The company utilizes Internet of Things (IoT) innovations and digitization to provide a comprehensive service for industrial and logistics enterprises, encompassing leasing, repair, and sales of complete machines and accessories. Furthermore, Folangsi has established more than 100 direct service outlets in major industrial cities across China.

Folangsi Co Ltd will list on November 10, 2023, in Hong Kong. The firm intends to offer 12.14 million shares at an expected price range of HKD 14.18 to 16.18. The total offer size is HKD 196.36M (approximately USD 25.05M). GF Securities Hong Kong Brokerage Ltd and Huatai Financial Holdings Hong Kong Ltd are managing the offering. Liugong Machinery Hongkong Co. is identified as a cornerstone investor.

2517 HK

Offer Price HKD 5.98

Filing Amount HKD 411.44M

Shares Offered 68.80M

2451 HK

Exp Price Range HKD 6.00 - 8.00

Filing Amount HKD 853.34M

Shares Offered 106.67M

9676 HK

Offer Price HKD 15.36

Pre Shoe Amount HKD 820.34M

Shares Offered   53.41M

2451 HK

Exp Price Range HKD 6.00 - 8.00

Filing Amount HKD 853.34M

Shares Offered 106.67M

6682 HK

Exp Price Range HKD 55.60 - 61.16

Filing Amount HKD 1.13B

Shares Offered 18.40M

9686 HK

Exp Price Range HKD 4.76 - 5.91

Filing Amount HKD 790.79M

Shares Offered 133.81M